[Product name] General name: Ilaprazole Enteric-coated Tablets [Composition] Main ingredients: Ilaprazole [Description] Ilaprazole is an enteric-coated tablet and is white or off-white when the coating is removed. [Indications] It is indicated for treatment of duodenal ulcer and reflux esophagitis. [Strength] 5 mg
[GenericName]IlaprazoleSodiumforInjection [Ingredient] Theactiveingredientisilaprazolesodium. [Description] Theproductiswhiteoroff-whitelooselumporpowder. [Indication] Pepticulcerhemorrhage [Strength] 10mg(calculatedasC19H18N4O2S) [DosageandAdministration] Intravenousdrip:theinitialdoseis20mg,followedby10mgofinjectioneachtimeforthreeconsecutivedays.Afterthetreatmentcourse,oralmedicationmaybegivenasappropriate. [Contraindication] Theproductiscontraindicatedinpatientsallergictoilaprazole,benzeneandimidazolecompounds,oranyotheringredientsinthisproduct. [Storage] Sealedandstorebelow25℃awayfromlight [ShelfLife]24months
[INDICATlONS] Benefiting vital energy and strengthening physique. It is for the treatment of weakness and tiredness, lassitude, spontaneous sweating, vertigo which are caused by the energy deficiency of lung and spleen. It is also the adjuvant therapy for the patients of lung cancer and stomach cancer with the above symptoms. [DOSAGE AND ADMINISTRATION] Intravenous drip of 250 ml once a day with a course of 21 days, for combining with chemotherapy. The treatment starts 3 days before the chemotherapy, and be synchronized ended with chemotherapy. [ADVERSE REACTIONS] 1. The patients with non-deficiency of vital energy may have mild bleeding after administration. 2. Small number of patients may have low fever, stomatitis and sleepiness after administration 3. Occasionally, rash, injection site pain, aversion to cold, chills, high fever, vomit, chest distress, palpitation may occur to patients after administration.
[Product Name] Menotropins for Injection [Composition] Menotropins for Injection is a preparation of glycoprotein gonadotropins, extracted from the urine of postmenopausal women. Each vial contains 75 International Units (IU) of follicle-stimulating hormone (FSH) activity and 75 IU of luteinizing hormone (LH) activity.
[Product Name] Kanamycin (as sulfate) Solution for Injection [Qualitative and Quantitative Composition] 500mg: 1 ampoule of 2 mL contains 500 mg kanamycin (as sulfate) 1000mg: 1 ampoule of 3 mL contains 1000mg kanamycin (as sulfate) [Package] 500 mg: 1 ampoule of 2 ml sterile solution for injection, 10 ampoules in 1 paper box 1000 mg: 1 ampoule with 3 ml sterile solution for injection, 10 ampoules in 1 paper box
[Product Name] Leuprorelin Acetate Microspheres for Injection. [Composition] Main ingredients: copolymer of leuprorelin acetate and glycolide lactide （25：75）, gelatin, D-mannitol. [Indication] 1. Endometriosis 2.Hysteromyoma reduce and/or improve hysteromyoma accompanied by hypermenorrhea, hypogastralgia, back pain and anaemia and etc. 3. Premenopausal breast cancer with estrogen receptor positive. 4. Prostate cancer. 5. Central precocious puberty.
[Product Name] Urofollitropin for Injection [Composition] A preparation of Urofollitropin, which is a sterile lyophilized form after adding appropriate excipient. [Indication] 1. Treatment of anovulation (include Polycystic ovary syndrome) and be invalid to Clomiphene Citrate. 2. To assist ovarian hyperstimulation of reproductive technology.
[Product Name] Mouse nerve growth factor for Injection [Composition] The main ingredients are isolated from mouse submaxillary glands, a kind of active protein with 13.5Kd molecular weight. It also contains inactive ingredients e.g. mannitol, human albumin. [Indication] (1)Ocular diseases, peripheral neuropathies, diabetic polyneuropathy; (2)Skin ulcers, corneal ulcers (3)Hypoxic-ischemic perinatal brain injury, alzheimer’s disease (AD) and other dementia, spinal cord neuron damage; [Dosage and Administration] Dissolve with 2ml sodium chloride injection or sterile water for injection before use. Intramuscular injection at the dosage of 30μg daily (one vial), one time each day and 3 to 6 weeks for one course of the treatment.